Heart Health
RNA Processing Protein Srsf3 Protects Against Atherosclerosis by Maturing Macrophages
New research reveals how a key RNA processing protein helps immune cells mature properly to fight artery plaque buildup.
Research Paper
Apr 2, 2026 0
Results for "Phosphatidylserine" in Heart Disease
20 articles
Heart Health
New Drug Sotatercept Shows Promise for Heart Failure with Preserved Ejection Fraction
Sotatercept emerges as potential treatment for combined pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction.
Research Paper
Mar 30, 2026 0
Heart Health
First Oral PCSK9 Inhibitor MK-0616 Shows Promise for Cholesterol Management
New oral drug MK-0616 matches injectable PCSK9 inhibitors for lowering LDL cholesterol while offering patient-friendly pill form.
Research Paper
Apr 7, 2026 0
Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Research Paper
May 29, 2026 0
Heart Health
PCSK9 Inhibitor AK102 Tested Against High-Risk Hypercholesterolemia in Phase 2 Trial
Akeso's AK102 faces a placebo-controlled test in high-cardiovascular-risk patients already on statins and ezetimibe.
Clinical Trial
May 27, 2026 0
Heart Health
Olpasiran Slashes Lp(a) Levels in Phase 2 Cardiovascular Trial
Amgen's siRNA therapy olpasiran targets lipoprotein(a), a stubborn cardiovascular risk factor with no approved treatments.
Clinical Trial
Jun 14, 2026 0
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Heart Health
Obicetrapib Shows Promise for Heart Disease and Alzheimer's Prevention
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
Podcast
Apr 2, 2026 0
Heart Health
Pfizer's PCSK9 Inhibitor Bococizumab Put to the Test in High-Risk Hyperlipidemia
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
Clinical Trial
Jun 8, 2026 0
Heart Health
Sex Hormones May Control Key Cholesterol Protein PCSK9 Differently in Men and Women
Study investigates why cholesterol-regulating protein PCSK9 responds differently to hormones in men versus women.
Clinical Trial
Mar 28, 2026 2
Heart Health
Personalized Cholesterol Management Could Slash Stroke Risk by Over 20 Percent
New research reveals how individualized lipid therapy based on stroke type and genetics could dramatically improve prevention outcomes.
Research Paper
Mar 29, 2026 2
Heart Health
PCSK9 Inhibitors Cut Heart Attack Risk 37% in Peripheral Artery Disease Patients
New meta-analysis shows PCSK9 inhibitors significantly reduce cardiovascular events and major amputations in PAD patients beyond standard statin therapy.
Research Paper
Mar 28, 2026 0
Heart Health
New PCSK9 Inhibitors Could Revolutionize Heart Disease Prevention and Longevity
Advanced cholesterol-lowering therapies show promise for dramatically reducing cardiovascular disease risk through innovative approaches.
Research Paper
Mar 28, 2026 0
Heart Health
Massive Study Debunks Most Statin Side Effects as Placebo Responses
Analysis of 123,940 patients reveals most reported statin side effects occur equally in placebo groups, challenging widespread medication fears.
Press Release
Mar 29, 2026 6
Heart Health
Anacetrapib Added to Statins Tested for Cholesterol Control in Phase 3 Trial
Merck's CETP inhibitor anacetrapib was evaluated alongside statin therapy to assess LDL-C lowering and HDL-C raising in hypercholesterolemia patients.
Clinical Trial
Jun 15, 2026 0
Heart Health
New Molecule Discovery Could Prevent Blindness and Heart Disease
Scientists found that boosting ApoM levels helps clear harmful cholesterol deposits that cause age-related vision loss and heart problems.
Press Release
Mar 29, 2026 1
Heart Health
New RNA Drug Olpasiran Slashes Heart Disease Risk Factor by 95 Percent
Breakthrough siRNA therapy dramatically reduces lipoprotein(a), a stubborn cardiovascular risk factor resistant to statins and lifestyle changes.
Research Paper
Mar 28, 2026 0
Heart Health
PCSK9 Inhibitors Cut Heart Disease Risk Across Multiple Patient Groups
New cholesterol drugs show powerful cardiovascular protection beyond statins with excellent safety profile.
Research Paper
Mar 28, 2026 0
Heart Health
Targeting Plaque Macrophages Shows Promise for Slowing Atherosclerosis Progression
New research reveals how modulating immune cells in arterial plaques could reduce cardiovascular disease progression.
Research Paper
Mar 28, 2026 0
Heart Health
New PCSK9 Inhibitor Lerodalcibep Heads to Head Against Evolocumab in Rare Cholesterol Disorder
A Phase 3 trial pits monthly lerodalcibep against evolocumab in homozygous familial hypercholesterolemia patients over 24 weeks.
Clinical Trial
Jun 16, 2026 0
Page 1 of 2Next